Can I read Alectinib (ALECENSA) Approval Overview on EtoBox?

Alectinib (ALECENSA) Approval Overview by Ioana Ghirvu is a document available to read on EtoBox.

What is Alectinib (ALECENSA) Approval Overview about?

This document summarizes information about the drug Alectinib (Alecensa), including its approval history, clinical trial results, and safety and efficacy data. Alectinib was approved to treat ALK-positive metastatic non-small cell lung cancer. It demonstrated improved progression-free survival compared to crizotinib in a clinical trial. Common side effects included fatigue, constipation, and edema. The approval was based on evidence that Alectinib is effective for the patient population and has a manageable

Author

Ioana Ghirvu

Language

EN